Baclofen and Vigabatrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Baclofen (baclofen) and Vigabatrin (vigabatrin). Common drug interactions include drug ineffective among females and seizure among males.

The phase IV clinical study analyzes what interactions people have when they take Baclofen and Vigabatrin. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Baclofen?

Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,662 Baclofen users. Check the latest studies of Baclofen.

What is Vigabatrin?

Vigabatrin has active ingredients of vigabatrin. eHealthMe is studying from 4,046 Vigabatrin users. Check the latest studies of Vigabatrin.

On Jul, 08, 2026

77 people who take Baclofen and Vigabatrin together, and have interactions are studied.

Baclofen and Vigabatrin drug interactions.

What are the common drug interactions of Baclofen and Vigabatrin, by gender? *:

female:

Drug ineffective
Adverse event
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Pneumonia
Cardiac arrest
Cardiac failure
Tracheostomy infection (infection of trachea surgical opening)
Depressed level of consciousness
Dystonia (abnormal muscle tone)
Encephalitis (inflammation of the brain)

male:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Acute respiratory failure
Gastritis (inflammation of stomach)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Respiration (transport of oxygen from the outside air to the cells within tissues)
Viral infection
Adverse event
Hypotension (abnormally low blood pressure)
Cardiac arrest
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)

What are the common drug interactions of Baclofen and Vigabatrin, by age (0-1 to 60+)? *:

0-1:

Drug ineffective
Acute respiratory failure
Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
Catarrh (inflammation of mucous membranes, especially of the nose and throat)
Cough
Depressed level of consciousness
Dystonia (abnormal muscle tone)
Encephalitis (inflammation of the brain)
Enterovirus infection
Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)

2-9:

Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light)
Urinary tract infection
Biliary tract disorder
Gastritis (inflammation of stomach)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Respiration (transport of oxygen from the outside air to the cells within tissues)
Viral infection
Hypotension (abnormally low blood pressure)
Somnolence (a state of near-sleep, a strong desire for sleep)
Adverse event

10-19:

Adverse drug reaction
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Hospitalisation
Infection
Pneumonia

20-29:

Bacterial toxaemia (blood contains bacterial toxins)

30-39:

n/a

40-49:

n/a

50-59:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)

60+:

n/a

What are the existing conditions these people have? *

Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 14 people, 18.18%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 14 people, 18.18%
Infantile Spasms: 11 people, 14.29%
Pneumonia: 8 people, 10.39%
Movement - Uncontrolled Or Slow: 8 people, 10.39%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 9.09%
Pain: 5 people, 6.49%

* Approximation only. Some reports may have incomplete information.

Do you take Baclofen and Vigabatrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously